Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

CUSIP: G2847J104

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Ordinary Shares, $0.0001 par value
Shares outstanding
33,549,784
Total 13F shares
22,407,322
Share change
+837,176
Total reported value
$230,112,841
Price per share
$10.27
Number of holders
38
Value change
+$8,645,514
Number of buys
16
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP G2847J104?
CUSIP G2847J104 identifies DMAA - Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA) as of Q3 2025

As of 30 Sep 2025, Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,407,322 shares. The largest 10 holders included Karpus Management, Inc., First Trust Capital Management L.P., Polar Asset Management Partners Inc., GLAZER CAPITAL, LLC, Westchester Capital Management, LLC, Hudson Bay Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC, MIZUHO SECURITIES USA LLC, ARISTEIA CAPITAL, L.L.C., and D. E. Shaw & Co., Inc.. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.